°³¿ä
À̺¥Æ® ¼Ò°³
¾ÆÁ¨´Ù
ÇÁ·Î±×·¥
Ç÷¹³Ê¸® ¼¼¼Ç(±âÁ¶ °¿¬)
¿¬»ç
Âü°¡ÀÚ
½ºÆù¼/Àü½Ã±â¾÷
½ºÆù¼
Àü½Ã±â¾÷ Ç÷ξîÇ÷£
¹Ìµð¾î
°³ÃÖÁö
Æ÷½ºÅÍ
¹®ÀÇ
Âü°¡½Åû
½ºÆù¼
Corporate Sponsors
Corporate Support Sponsors
Choose your language
¤ý¿øÈ °áÁ¦ °¡´É
¤ý¼ö¼ö·á ¹«·á
¤ýÁõºù ¼·ù Á¦°ø °¡´É
(°Å·¡¸í¼¼¼, °è»ê¼ µî)
ÄÁÆÛ·±½º ÇÁ·Î±×·¥
9¿ù 22ÀÏ
Covalent Chemistries & Induced Proximity
°øÀ¯°áÇÕ ÈÇС¤À¯µµ Á¢±Ù
Strategies for Targeting Kinases
Ű³ª¾ÆÁ¦¸¦ Ç¥ÀûÀ¸·Î ÇÏ´Â Àü·«
Emerging Immune Modulation Strategies
½Å±Ô ¸é¿ª Á¶Àý Àü·«
3D Models & NAMs in Drug Development
ÀǾàǰ °³¹ß¿¡¼ÀÇ 3D ¸ðµ¨¡¤NAM
Synthetic Biology for Drug Discovery & Development
Drug Discovery¡¤ÀǾàǰ °³¹ßÀÇ ÇÕ¼º»ý¹°ÇÐ
9¿ù 23ÀÏ-24ÀÏ
Degraders & Molecular Glues – Part 1
ºÐÇØÁ¦¡¤ºÐÀÚÁ¢ÂøÁ¦ - ÆÄÆ® 1
Emerging Drug Targets: Identification & Validation
½Å±Ô ÀǾàǰ Ÿ°Ù£º½Äº°¡¤¹ë¸®µ¥À̼Ç
Small Molecules for Cancer Targets
¾ÏÇ¥ÀûÀÇ ÀúºÐÀÚ
Antibodies Against Membrane Protein Targets
¸·´Ü¹éÁú Ÿ°Ù¿¡ ´ëÇÑ Ç×ü
RNA & DNA Targeting Small Molecule Drugs
RNA¡¤DNA Ç¥Àû ÀúºÐÀÚ ÀǾàǰ
AI/ML-Enabled Drug Discovery - Part 1
AI/ML ´ëÀÀ Drug Discovery - ÆÄÆ® 1
Targeting MASH & Obesity
NEW
MASH¡¤ºñ¸¸ Ç¥Àû
9¿ù 24ÀÏ-25ÀÏ
Degraders & Molecular Glues – Part 2
ºÐÇØÁ¦¡¤ºÐÀÚÁ¢ÂøÁ¦ - ÆÄÆ® 2
Lead Generation Strategies
¸®µå Á¦³Ê·¹ÀÌ¼Ç Àü·«
Emerging Cancer Targets for Multispecifics, ADCs, and Biologics
´ÙÁ߯¯À̼º¡¤ADC¡¤¹ÙÀÌ¿À·ÎÁ÷½ºÀÇ ½Å±Ô ¾ÏÇ¥Àû
GPCR-Based Drug Discovery
GPCR ±â¹Ý Drug Discovery
Targeting Transcription Factors & Regulators
Àü»ç ÀÎÀÚ¡¤Á¦¾î ÀÎÀÚ Ç¥Àû
AI/ML-Enabled Drug Discovery - Part 2
AI/ML ´ëÀÀ Drug Discovery - ÆÄÆ® 2
TS: Drug Exposure at the Target: The Role of ADME and Pharmacokinetics
TS£ºÅ¸°Ù¿¡¼ÀÇ ¾àÁ¦ Æø·Î£ºADME¿Í ¾à¹° µ¿ÅÂÀÇ ¿ªÇÒ